Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Case report: benefits of quantitative polymerase chain reaction in the clinical management of herpes simplex virus 1 infection with prominent hepatitis and unusual secondary progression.
Chaillon A, Schnepf N, Jonas M, Mondon K, Orain I, Lioger B, Cottier JP, Hommet C, Goudeau A.
J Med Virol. 2012 Mar;84(3):457-61. doi: 10.1002/jmv.23230.
Related citations
Development of a hepatitis delta virus antibody assay for study of the prevalence of HDV among individuals infected with hepatitis B virus in China.
Shen L, Gu Y, Sun L, Yang Y, Wang F, Li Y, Bi S.
J Med Virol. 2012 Mar;84(3):445-9. doi: 10.1002/jmv.23212.
Prevalence of hepatitis C virus genotype 1a in Japan and correlation of mutations in the NS5A region and single-nucleotide polymorphism of interleukin-28B with the response to combination therapy with pegylated-interferon-alpha 2b and ribavirin.
Hayashi K, Katano Y, Kuzuya T, Tachi Y, Honda T, Ishigami M, Itoh A, Hirooka Y, Ishikawa T, Nakano I, Urano F, Yoshioka K, Toyoda H, Kumada T, Goto H.
J Med Virol. 2012 Mar;84(3):438-44. doi: 10.1002/jmv.23207.
Quantitation of hepatitis C virus RNA in peripheral blood mononuclear cells in HCV-monoinfection and HIV/HCV-coinfection.
Chary A, Winters MA, Eisen R, Knight TH, Asmuth DM, Holodniy M.
J Med Virol. 2012 Mar;84(3):431-7. doi: 10.1002/jmv.23210.
Antiviral efficacy of combination therapy with entecavir and adefovir for entecavir/lamivudine-resistant hepatitis B virus with or without adefovir resistance.
Yang HJ, Lee JH, Kim YJ, Yoon JH, Lee HS.
J Med Virol. 2012 Mar;84(3):424-30. doi: 10.1002/jmv.23229.
Characterization of hepatitis B virus genome variability in Iranian patients with chronic infection, a nationwide study.
Mohebbi SR, Amini-Bavil-Olyaee S, Zali N, Damavand B, Azimzadeh P, Derakhshan F, Sabahi F, Zali MR.
J Med Virol. 2012 Mar;84(3):414-23. doi: 10.1002/jmv.23200.
Analysis of a non-structural gene reveals evidence of possible hepatitis C virus (HCV) compartmentalization.
Blackard JT, Ma G, Welge JA, Martin CM, Sherman KE, Taylor LE, Mayer KH, Jamieson DJ.
J Med Virol. 2012 Feb;84(2):242-52. doi: 10.1002/jmv.22269.
Demographics, socio-behavioral factors, and drug use patterns: what matters in spontaneous HCV clearance?
Shah DP, Grimes CZ, Brown E, Hwang LY.
J Med Virol. 2012 Feb;84(2):235-41. doi: 10.1002/jmv.22271.
A point mutation at Asn-534 that disrupts a conserved N-glycosylation motif of the E2 glycoprotein of hepatitis C virus markedly enhances the sensitivity to antibody neutralization.
Sasayama M, Shoji I, Adianti M, Jiang DP, Deng L, Saito T, Watanabe H, Kawata S, Aoki C, Hotta H.
J Med Virol. 2012 Feb;84(2):229-34. doi: 10.1002/jmv.22257.
Hepatitis C virus genotyping in Greece: unexpected high prevalence of genotype 5a in a Greek island.
Karatapanis S, Tsoplou P, Papastergiou V, Vasiageorgi A, Stampori M, Saitis I, Tsitsopoulos E, Lisgos P, Skorda L, Ketikoglou I, Goulis I.
J Med Virol. 2012 Feb;84(2):223-8. doi: 10.1002/jmv.22249.
Pre-existing YMDD mutants in treatment-naïve patients with chronic hepatitis B are not selected during lamivudine therapy.
Lee SH, Kim HS, Byun IS, Jeong SW, Kim SG, Jang JY, Kim YS, Kim BS.
J Med Virol. 2012 Feb;84(2):217-22. doi: 10.1002/jmv.23191.
Discrepancy of potential antiviral resistance mutation profiles within the HBV reverse transcriptase between nucleos(t)ide analogue-untreated and -treated patients with chronic hepatitis B in a hospital in China.
Li XG, Liu BM, Xu J, Liu XE, Ding H, Li T.
J Med Virol. 2012 Feb;84(2):207-16. doi: 10.1002/jmv.23182.
Comprehensive analysis of the prevalence of hepatitis B virus escape mutations in the major hydrophilic region of surface antigen.
Ma Q, Wang Y.
J Med Virol. 2012 Feb;84(2):198-206. doi: 10.1002/jmv.23183.
Prevalence of specific antibody to hepatitis E virus in the general population of the community of Madrid, Spain.
Fogeda M, Avellón A, Echevarría JM.
J Med Virol. 2012 Jan;84(1):71-4. doi: 10.1002/jmv.22270.
Predictive value of early viral dynamics during peginterferon and ribavirin combination therapy based on genetic polymorphisms near the IL28B gene in patients infected with HCV genotype 1b.
Toyoda H, Kumada T, Tada T, Hayashi K, Honda T, Katano Y, Goto H, Kawaguchi T, Murakami Y, Matsuda F.
J Med Virol. 2012 Jan;84(1):61-70. doi: 10.1002/jmv.22272.
Human platelet antigen genotype is associated with progression of fibrosis in chronic hepatitis C.
Silva GF, Grotto RM, Verdichio-Moraes CF, Corvino SM, Ferrasi AC, Silveira LV, Pardini MI.
J Med Virol. 2012 Jan;84(1):56-60. doi: 10.1002/jmv.22191.
Mutations within enhancer II and BCP regions of hepatitis B virus in relation to advanced liver diseases in patients infected with subgenotype B3 in Indonesia.
Heriyanto DS, Yano Y, Utsumi T, Anggorowati N, Rinonce HT, Lusida MI, Soetjipto, Triwikatmani C, Ratnasari N, Maduseno S, Purnama PB, Nurdjanah S, Hayashi Y.
J Med Virol. 2012 Jan;84(1):44-51. doi: 10.1002/jmv.22266.
Prevalence and impact of hepatitis B and C virus co-infections in antiretroviral treatment naïve patients with HIV infection at a major treatment center in Ghana.
Sagoe KW, Agyei AA, Ziga F, Lartey M, Adiku TK, Seshi M, Arens MQ, Mingle JA.
J Med Virol. 2012 Jan;84(1):6-10. doi: 10.1002/jmv.22262.
Near-full genome characterization of unclassified hepatitis C virus strains relating to genotypes 1 and 4.
Demetriou VL, Kostrikis LG.
J Med Virol. 2011 Dec;83(12):2119-27. doi: 10.1002/jmv.22237.
Transmission of hepatitis C virus among spouses in Cameroon and the Central African Republic.
Njouom R, Lavoie M, Foupouapouognigni Y, Frost E, Deslandes S, Mamadou-Yaya F, Mbélesso P, Mbadingai S, Pépin J.
J Med Virol. 2011 Dec;83(12):2113-8. doi: 10.1002/jmv.22225.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on